Barclays’s Telomir Pharmaceuticals TELO Stock Holding History
Bought
Maintained
Sold
Other funds holding TELO
PWM
Barclays's TELO Position: Q3 2026 in Review
Barclays sold out of Telomir Pharmaceuticals (TELO) in Q3 2026, closing a stake of 553 shares — an estimated $708 sold.
Barclays first reported a position in TELO in Q2 2024 and held it in 8 quarters. The position peaked at $123K in Q4 2024. 23 funds tracked by Wall St. Rank hold TELO as of Q3 2026.
- Barclays reported no remaining Telomir Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Barclays sold 553 Telomir Pharmaceuticals shares in Q3 2026, an estimated $708.
- Barclays first reported a position in Telomir Pharmaceuticals in Q2 2024 and held it in 8 quarters.
- Barclays's Telomir Pharmaceuticals position peaked at $123K in Q4 2024.
- 23 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.